This site is intended for healthcare professionals
FDA Hero Banner - Multi-coloured pills and tablets
FDA Drug information

Dipyridamole

Read time: 1 mins
Marketing start date: 28 Apr 2024
...
 

Summary of product characteristics


Effective Time

20220825

Version

7

Spl Product Data Elements

Dipyridamole Dipyridamole DIPYRIDAMOLE DIPYRIDAMOLE FERRIC OXIDE YELLOW HYPROMELLOSES LACTOSE MONOHYDRATE MAGNESIUM STEARATE POLYETHYLENE GLYCOL, UNSPECIFIED POVIDONE TITANIUM DIOXIDE STARCH, CORN LIGHT YELLOW ROUND ZE;43 Dipyridamole Dipyridamole DIPYRIDAMOLE DIPYRIDAMOLE FERRIC OXIDE YELLOW HYPROMELLOSES LACTOSE MONOHYDRATE MAGNESIUM STEARATE POLYETHYLENE GLYCOL, UNSPECIFIED POVIDONE TITANIUM DIOXIDE STARCH, CORN LIGHT YELLOW ROUND ZE;49 Dipyridamole Dipyridamole DIPYRIDAMOLE DIPYRIDAMOLE FERRIC OXIDE YELLOW HYPROMELLOSES LACTOSE MONOHYDRATE MAGNESIUM STEARATE POLYETHYLENE GLYCOL, UNSPECIFIED POVIDONE TITANIUM DIOXIDE STARCH, CORN LIGHT YELLOW ROUND ZE;50

Application Number

ANDA040874

Brand Name

Dipyridamole

Generic Name

Dipyridamole

Product Ndc

65841-663

Product Type

HUMAN PRESCRIPTION DRUG

Route

ORAL

Package Label Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL NDC 65841-662-01 in bottle of 100 tablets Dipyridamole Tablets USP, 25 mg R x only 100 tablets ZYDUS NDC 65841-663-01 in bottle of 100 tablets Dipyridamole Tablets USP, 50 mg R x only 100 tablets ZYDUS NDC 65841-664-01 in bottle of 100 tablets Dipyridamole Tablets USP, 75 mg R x only 100 tablets ZYDUS Dipyridamole Tablets, 25 mg Dipyridamole Tablets, 50 mg Dipyridamole Tablets, 75 mg

Drug section

CME banner

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.

Click here to view

Disclaimer

The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).

Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.

Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.